Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The Dementia Discovery Fund (DDF) is a venture capital fund managed by SV Health Investors, founded in 2015. Based in London and Boston, DDF has raised over $600 million to focus on companies that develop or enable novel therapeutics for dementia. The fund aims to deliver measurable impact while generating financial returns.
DDF invests in companies across the full spectrum of company and asset stages, specifically targeting innovative projects informed by advanced science that can benefit dementia patients. The fund's investment strategy includes exploring novel hypotheses and expanding the range of targets and mechanisms for dementia therapies, starting from target identification.
DDF often leads investment rounds, particularly in early-stage projects that align with their focus on dementia therapeutics.
The fund is open to follow-on investments in companies that demonstrate significant progress and potential in their therapeutic development.
DDF has a fund size of $600 million, which supports its investment strategy in the dementia therapeutics space.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.